โ† Wiki Index / Microbiology & Immunology / Lectin Pathway of Complement Activation
๐Ÿฆ  Microbiology & Immunology

Lectin Pathway of Complement Activation

The lectin pathway is an antibody-independent innate immune cascade initiated when pattern recognition molecules such as mannose-binding lectin or ficolins bind microbial surface carbohydrates and activate MASP serine proteases.

Lectin pathway of complement activation is one of the three principal biochemical cascades that constitute the innate complement system, operating alongside the classical and alternative pathways. Discovered in the late twentieth century through the pioneering work of Teizo Fujita, Misao Matsushita, and Jens Christian Jensenius, the lectin pathway functions as an antibody-independent surveillance mechanism that detects conserved repeating carbohydrate patterns on invading microbial surfaces. The pathway utilizes soluble pattern recognition molecules (PRMs)โ€”specifically mannose-binding lectin (MBL), ficolins (M-ficolin, L-ficolin, and H-ficolin), and collectin-10/11โ€”associated with MBL-associated serine proteases (MASP-1, MASP-2, and MASP-3).

Upon engaging microbial glycans such as D-mannose, N-acetylglucosamine (GlcNAc), or beta-glucans, the PRMs undergo conformational transitions that trigger the sequential activation of MASP-1 and MASP-2. Activated MASP-2 cleaves complement components C4 and C2 to form the classical/lectin C3 convertase (C4b2a), directing opsonization, inflammatory leukocyte recruitment, and assembly of the membrane attack complex. Because it operates independently of adaptive immunoglobulin production, the lectin pathway provides immediate frontline protection against bacterial, fungal, and viral infections in early life.

Pattern Recognition Molecules: Collectins and Ficolins

The recognition complexes of the lectin pathway share structural architecture with the classical pathway's C1q subcomponent, assembling as high-order oligomeric bouquets with collagen-like stalks and globular recognition domains.

Molecular Architecture of Lectin Pathway Recognition:
[ Globular Recognition Heads: CRD / Fibrinogen-like ] (Carbohydrate Binding)
\ \ | / /
\ \ | / /
[ Collagenous Stems (Triple Helices) ]
|||
+-----------------------------+
| Catalytic Protease Complex: |
| [ MASP-1 ] === [ MASP-2 ] |
+-----------------------------+

Mannose-Binding Lectin and Collectins

Mannose-binding lectin (MBL) belongs to the collectin family of C-type lectins. The basic structural subunit is a trimer of identical polypeptide chains, each containing an N-terminal cysteine-rich region, an elongated collagen-like triple helix, a short neck region, and a C-terminal carbohydrate recognition domain (CRD).

The CRDs coordinate divalent calcium ions (Ca2+) to bind equatorial hydroxyl groups present on terminal mannose, fucose, and glucose residues. Monomeric binding affinities are modest; however, MBL oligomerizes into tetramers, pentamers, and hexamers of trimers. This multipronged floral bouquet achieves high avidity when binding to dense arrays of carbohydrates characteristic of bacterial lipopolysaccharides, fungal cell wall mannans, and viral envelope glycoproteins, while ignoring the sialylated, galactose-terminated carbohydrates typical of healthy mammalian cell membranes.

Ficolins and Collectin-11

Complementing MBL are three human ficolins: L-ficolin (ficolin-2), H-ficolin (ficolin-3), and M-ficolin (ficolin-1). Instead of C-type lectin CRDs, ficolins possess C-terminal fibrinogen-like recognition domains. Ficolins recognize acetylated compounds, binding avidly to N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) residues on capsular polysaccharides of Streptococcus pneumoniae, Staphylococcus aureus, and Aspergillus fumigatus. Collectin-11 (CL-K1) further expands pattern recognition by recognizing l-fucose and d-galactose determinants.

The MASP Protease Activation Relay

The enzymatic machinery of the lectin pathway resides in MBL-associated serine proteases (MASPs). Circulating PRMs form non-covalent complexes with three catalytic zymogens (MASP-1, MASP-2, and MASP-3) and two non-enzymatic truncated regulatory proteins (MAp19 and MAp44).

Two-Step Enzymatic Activation Mechanism:
PRM binds microbial cell wall (High Avidity)
|
v
Conformational strain across collagenous stems
|
v
MASP-1 autoactivates via trans-activation
|
v
Active MASP-1 cleaves proenzyme MASP-2
|
v
Active MASP-2 cleaves C4 and C2 ---> Forms C4b2a (C3 Convertase)

Structural crystallography and kinetic studies conducted by Russell Wallis and Christian Andersen demonstrated an essential division of labor between MASP-1 and MASP-2:

  1. Autoactivation of MASP-1: MASP-1 undergoes autoactivation upon multi-point ligand binding, as mechanical tension brings catalytic domains into reciprocal alignment to cleave an internal Arg-Ile peptide bond.
  2. MASP-2 Activation: Active MASP-1 then cleaves zymogen MASP-2. While MASP-2 can undergo slow autoactivation under specialized conditions, physiological activation relies predominantly on MASP-1 cleavage.
  3. Substrate Cleavage: Active MASP-2 exhibits high specificity for native complement components C4 and C2. MASP-2 cleaves C4 into C4a and C4b, and cleaves C2 into C2b and C2a, assembling the active C4b2a convertase on the target pathogen membrane.

Furthermore, MASP-3 plays an essential upstream role in the alternative complement pathway by cleaving pro-factor D into active factor D, demonstrating cross-pathway integration.

Clinical Relevance and Disease Associations

Genetic polymorphisms affecting the MBL2 gene on chromosome 10 are common in human populations, leading to functional MBL deficiency in up to 30 percent of individuals.

While MBL deficiency is often clinically silent in immunocompetent adults due to redundancy provided by the classical and alternative pathways, it presents significant risks during periods of immune vulnerability. Infants between six and eighteen months of ageโ€”a critical immunological window when maternal diaplacental IgG antibodies have waned but endogenous antibody production is immatureโ€”experience increased susceptibility to recurrent respiratory tract infections, meningococcal meningitis, and sepsis when deficient in MBL.

In adult clinical medicine, dysregulated lectin pathway activation contributes to ischemia-reperfusion injury following myocardial infarction, organ transplantation, and ischemic stroke. During tissue ischemia, hypoxic endothelial cells expose neo-epitopes that bind MBL and ficolins, triggering complement-mediated inflammation and neutrophil infiltration into viable heart or brain tissue. Consequently, monoclonal antibodies targeting MASP-2 (such as narsoplimab) have entered clinical trials to treat complement-mediated microangiopathies, including atypical hemolytic uremic syndrome and hematopoietic stem cell-associated thrombotic microangiopathy.

References

  1. Matsushita, M., & Fujita, T. (2001). Ficolins and the lectin complement pathway. Immunological Reviews, 180(1), 78โ€“85. https://doi.org/10.1034/j.1600-065x.2001.1800107.x
  2. Fujita, T., Matsushita, M., & Endo, Y. (2004). The lectin-complement pathwayโ€”its role in innate immunity and evolution. Immunological Reviews, 198(1), 185โ€“202. https://doi.org/10.1111/j.0105-2896.2004.0123.x
  3. Wallis, R., Mitchell, D. A., Schmid, R., Schwaeble, W. J., & Keeble, A. H. (2010). Paths reunited: Initiation of the classical and lectin pathways of complement activation. Immunobiology, 215(1), 1โ€“11. https://doi.org/10.1016/j.imbio.2009.08.006
๐Ÿงฌ Support Open Science
Explore interactive science games on LowKey Games or browse scientific apparel & accessories in the CRV Science Shop.
๐Ÿ’ก Spot an inaccuracy or have primary literature to expand this article?
Submit a citation or revision note using your shared CRV Science / LowKey Games profile ID.
Suggest Revision